These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18180761)

  • 1. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder.
    Saxena S; Gorbis E; O'Neill J; Baker SK; Mandelkern MA; Maidment KM; Chang S; Salamon N; Brody AL; Schwartz JM; London ED
    Mol Psychiatry; 2009 Feb; 14(2):197-205. PubMed ID: 18180761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism in obsessive-compulsive hoarding.
    Saxena S; Brody AL; Maidment KM; Smith EC; Zohrabi N; Katz E; Baker SK; Baxter LR
    Am J Psychiatry; 2004 Jun; 161(6):1038-48. PubMed ID: 15169692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional homogeneity of spontaneous brain activity in adult patients with obsessive-compulsive disorder before and after cognitive behavioural therapy.
    Yang XY; Sun J; Luo J; Zhong ZX; Li P; Yao SM; Xiong HF; Huang FF; Li ZJ
    J Affect Disord; 2015 Dec; 188():243-51. PubMed ID: 26378734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
    O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
    J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder.
    Mantione M; Nieman DH; Figee M; Denys D
    Psychol Med; 2014 Dec; 44(16):3515-22. PubMed ID: 25065708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cognitive behavioral therapy on resting-state functional brain network in drug-naive patients with obsessive-compulsive disorder.
    Li P; Yang X; Greenshaw AJ; Li S; Luo J; Han H; Liu J; Zhong Z; Guo Z; Xiong H; Yao S; Chen Y; Sun J; Li Z
    Brain Behav; 2018 May; 8(5):e00963. PubMed ID: 29761016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT.
    Huyser C; Veltman DJ; Wolters LH; de Haan E; Boer F
    J Child Psychol Psychiatry; 2011 Dec; 52(12):1251-60. PubMed ID: 21793825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting response to cognitive behavioral therapy in contamination-based obsessive-compulsive disorder from functional magnetic resonance imaging.
    Olatunji BO; Ferreira-Garcia R; Caseras X; Fullana MA; Wooderson S; Speckens A; Lawrence N; Giampietro V; Brammer MJ; Phillips ML; Fontenelle LF; Mataix-Cols D
    Psychol Med; 2014 Jul; 44(10):2125-37. PubMed ID: 24229474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
    Saxena S; Brody AL; Ho ML; Alborzian S; Maidment KM; Zohrabi N; Ho MK; Huang SC; Wu HM; Baxter LR
    Arch Gen Psychiatry; 2002 Mar; 59(3):250-61. PubMed ID: 11879163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Definition of treatment-refractory obsessive-compulsive disorder based on cognitive behavioral therapy].
    Shimizu E
    Seishin Shinkeigaku Zasshi; 2013; 115(9):975-80. PubMed ID: 24228475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
    Saxena S; Brody AL; Ho ML; Zohrabi N; Maidment KM; Baxter LR
    Am J Psychiatry; 2003 Mar; 160(3):522-32. PubMed ID: 12611834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.
    Zuo C; Ma Y; Sun B; Peng S; Zhang H; Eidelberg D; Guan Y
    J Cereb Blood Flow Metab; 2013 Jun; 33(6):880-7. PubMed ID: 23443174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.
    Apostolova I; Block S; Buchert R; Osen B; Conradi M; Tabrizian S; Gensichen S; Schröder-Hartwig K; Fricke S; Rufer M; Weiss A; Hand I; Clausen M; Obrocki J
    Psychiatry Res; 2010 Nov; 184(2):105-16. PubMed ID: 20947317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
    O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
    Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    O'Neill J; Piacentini JC; Chang S; Levitt JG; Rozenman M; Bergman L; Salamon N; Alger JR; McCracken JT
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):161-8. PubMed ID: 21983143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.
    Schwartz JM; Stoessel PW; Baxter LR; Martin KM; Phelps ME
    Arch Gen Psychiatry; 1996 Feb; 53(2):109-13. PubMed ID: 8629886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder.
    Herbst N; Voderholzer U; Thiel N; Schaub R; Knaevelsrud C; Stracke S; Hertenstein E; Nissen C; Külz AK
    Psychother Psychosom; 2014; 83(3):165-75. PubMed ID: 24732962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting-state connectivity of the amygdala predicts response to cognitive behavioral therapy in obsessive compulsive disorder.
    Göttlich M; Krämer UM; Kordon A; Hohagen F; Zurowski B
    Biol Psychol; 2015 Oct; 111():100-9. PubMed ID: 26388257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.